Because of their substantial benefit on some of the most highly prevalent disorders worldwide, GLP-1RAs have been hailed as game changers 8,9 and breakthrough drugs 10 , with an estimated market value of US$22.4 billion in 2022 and a compound annual growth rate of around 9.6% between 2023 and 2032 11
GLP-1 medications improve insulin sensitivity in liver cells, reduce oxidative stress, and activate cellular cleaning processes like macroautophagy that help remove excess fat 19
J Hepatol 2024;81:492-542.ArticlePubMed 100
Prokinetics in patients with gastroparesis: a systematic analysis
By now, unless you reside on Mars, youre plenty familiar with the names Ozempic and Wegovy
Some people are trying microdosingtaking smaller, flexible doses, often through compounded versions of these medicationsto minimize side effects while still reaping benefits